198 related articles for article (PubMed ID: 20351091)
1. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility.
Wang H; Teh MT; Ji Y; Patel V; Firouzabadian S; Patel AA; Gutkind JS; Yeudall WA
Carcinogenesis; 2010 Jun; 31(6):1132-41. PubMed ID: 20351091
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
[TBL] [Abstract][Full Text] [Related]
4. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
5. Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation.
Ngan AWL; Grace Tsui M; So DHF; Leung WY; Chan DW; Yao KM
Front Oncol; 2019; 9():154. PubMed ID: 30941306
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
7. Role for EPS8 in squamous carcinogenesis.
Wang H; Patel V; Miyazaki H; Gutkind JS; Yeudall WA
Carcinogenesis; 2009 Jan; 30(1):165-74. PubMed ID: 19008210
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival.
Xu M; Shorts-Cary L; Knox AJ; Kleinsmidt-DeMasters B; Lillehei K; Wierman ME
Endocrinology; 2009 May; 150(5):2064-71. PubMed ID: 19116338
[TBL] [Abstract][Full Text] [Related]
9. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
[TBL] [Abstract][Full Text] [Related]
10. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
11. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
[TBL] [Abstract][Full Text] [Related]
12. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
He SY; Shen HW; Xu L; Zhao XH; Yuan L; Niu G; You ZS; Yao SZ
Gynecol Oncol; 2012 Dec; 127(3):601-10. PubMed ID: 22943878
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
15. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression.
Cheng SX; Tu Y; Zhang S
PLoS One; 2013; 8(8):e72376. PubMed ID: 23991102
[TBL] [Abstract][Full Text] [Related]
17. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells.
Dai B; Kang SH; Gong W; Liu M; Aldape KD; Sawaya R; Huang S
Oncogene; 2007 Sep; 26(42):6212-9. PubMed ID: 17404569
[TBL] [Abstract][Full Text] [Related]
18. c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8).
Mitra S; Lee JS; Cantrell M; Van den Berg CL
J Biol Chem; 2011 Apr; 286(17):15287-97. PubMed ID: 21357683
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ELDR promotes cell cycle progression in normal oral keratinocytes through induction of a CTCF-FOXM1-AURKA signaling axis.
Sur S; Steele R; Ko BCB; Zhang J; Ray RB
J Biol Chem; 2022 May; 298(5):101895. PubMed ID: 35378133
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
